SAM
PRAX icon

Smartleaf Asset Management’s Praxis Precision Medicines PRAX Stock Holding History

Smartleaf Asset Management’s Portfolio PRAX Stock Details PRAX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$34.7K Hold
99
– – ﹤0.01% 1700
2026
Q1 		$27.4K Buy
99
+25
+34% +$7.73K ﹤0.01% 1788
2025
Q4 		$22K Buy
+74
New +$13.8K ﹤0.01% 1980

Other funds holding PRAX

JT
Jupiter Topco New York $245B AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
OAG
Orbis Allan Gray Hamilton, Bermuda $29.1B AUM 60.8% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return

Smartleaf Asset Management's PRAX Position: Q2 2026 in Review

Smartleaf Asset Management held its Praxis Precision Medicines (PRAX) position steady in Q2 2026 at 99 shares worth $34.7K. The position accounts for ﹤0.01% of the portfolio, ranked #1700.

Smartleaf Asset Management first reported a position in PRAX in Q4 2025 and has held it in 3 quarters since. 309 funds tracked by Wall St. Rank hold PRAX as of Q2 2026.

  • Smartleaf Asset Management held 99 shares of Praxis Precision Medicines worth $34.7K as of Q2 2026.
  • Smartleaf Asset Management left its Praxis Precision Medicines share count unchanged in Q2 2026.
  • Praxis Precision Medicines made up ﹤0.01% of Smartleaf Asset Management's portfolio in Q2 2026, its #1700 holding.
  • Smartleaf Asset Management first reported a position in Praxis Precision Medicines in Q4 2025 and has held it in 3 quarters since.
  • 309 funds tracked by Wall St. Rank held Praxis Precision Medicines as of Q2 2026.

Based on Smartleaf Asset Management's 13F filing for Q2 2026, filed 12 Aug 2026.